FHA
RLAY icon

First Horizon Advisors’s Relay Therapeutics RLAY Stock Holding History

First Horizon Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-83
Closed -$588 – 2349
2024
Q3 		$588 Hold
83
– – ﹤0.01% 2207
2024
Q2 		$541 Sell
83
-710
-90% -$4.85K ﹤0.01% 2199
2024
Q1 		$6.58K Buy
793
+146
+23% +$1.42K ﹤0.01% 1739
2023
Q4 		$7.12K Buy
647
+227
+54% +$1.92K ﹤0.01% 1700
2023
Q3 		$3.53K Buy
420
+104
+33% +$1.12K ﹤0.01% 1847
2023
Q2 		$3.97K Sell
316
-221
-41% -$2.75K ﹤0.01% 1867
2023
Q1 		$8.84K Sell
537
-49
-8% -$879 ﹤0.01% 1602
2022
Q4 		$8.76K Buy
586
+35
+6% +$670 ﹤0.01% 1616
2022
Q3 		$12K Buy
551
+34
+7% +$746 ﹤0.01% 1451
2022
Q2 		$9K Buy
517
+501
+3,131% +$10.7K ﹤0.01% 1637
2022
Q1 		$0 Buy
+16
New +$388 ﹤0.01% 2184

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

First Horizon Advisors's RLAY Position: Q4 2024 in Review

First Horizon Advisors sold out of Relay Therapeutics (RLAY) in Q4 2024, closing a stake of 83 shares — an estimated $588 sold.

First Horizon Advisors first reported a position in RLAY in Q1 2022 and held it in 11 quarters. The position peaked at $12K in Q3 2022. 199 funds tracked by Wall St. Rank hold RLAY as of Q4 2024.

  • First Horizon Advisors reported no remaining Relay Therapeutics position as of Q4 2024 after selling out during the quarter.
  • First Horizon Advisors sold 83 Relay Therapeutics shares in Q4 2024, an estimated $588.
  • First Horizon Advisors first reported a position in Relay Therapeutics in Q1 2022 and held it in 11 quarters.
  • First Horizon Advisors's Relay Therapeutics position peaked at $12K in Q3 2022.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2024.

Based on First Horizon Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.